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Abstract
Background: Lack of knowledge regarding preventive health services for women might impede campaigns to
expand these services in the emergency department setting. For 18–55-year-old English-speaking women visiting
an urban emergency department, we aimed to: (1) Ascertain their knowledge regarding the applicability, purpose,
and recommended intervals of three women's cancer screening and three contraceptive methods; and (2)
Determine if patient age, race/ethnicity, medical insurance status, and current or recent usage of these methods
are associated with greater or lesser knowledge about them.
Methods: Emergency department-based survey on recent or current usage and knowledge about Pap smears,
breast self-examinations, mammograms, condoms, birth control, and emergency contraception. Analyses included
calculation of summary statistics and creation of multivariable logistic regression models.
Results: Of 1,100 patients eligible for the study, 69.9% agreed to participate. Most of the participants were < age
35, white, single (never married and no partner), Catholic, and had private medical insurance. Participant's recent
or current usage of a particular cancer screening or contraceptive method varied by type of method: Pap smear
within the past year (69.1%), breast self-exam within the past month (45.5%), mammogram within the past year
(65.7% for women age 45–55), condom usage during every episode of sexual intercourse (15.4%), current usage
of birth control pills (17.8%), and ever use of emergency contraception (9.3%). The participants correctly
answered 87.9% of all survey questions about condoms, 82.5% about birth control pills, 78.5% about breast self-
exams, 52.9% about Pap smears, 35.4% about mammograms, and 25.0% about emergency contraception. In
multivariable logistic regression models, survey participants who had private medical insurance and those who
recently or currently used a given screening or contraceptive method had a greater odds of correctly answering
all questions about each cancer screening or contraceptive method.
Conclusion: Although these female ED patients demonstrated strong knowledge on some women's cancer
screening and contraceptive methods, there were several areas of knowledge deficit. Women without private
medical insurance and those who have not used a particular cancer screening or contraceptive method
demonstrated less knowledge. Reduced knowledge about women's cancer screening and contraceptive methods
should be considered during clinical encounters and when instituting or evaluating emergency department-based
initiatives that assess the need for these methods.
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Background
In the United States, there were 107.5 million patient vis-
its to emergency departments (EDs) in 2001, of which
approximately half were by women [1]. For many women,
the ED is a common source for their medical care [2-4].
For some of these women, visiting the ED might be the
way they access or receive referrals for preventive care. In
1996, the US Preventive Services Task Force of the US
Department of Health and Human Services recom-
mended that clinicians use patient visits as opportunities
to provide preventive health services [5]. The Society for
Academic Emergency Medicine Public Health and Educa-
tion Task Force responded to this call and considered the
evidence amassed thus far in support of instituting or
expanding these services for the ED setting [6,7]. In many
cases, especially for women's preventive health, there were
few ED-based studies on the subject. As a result, definitive
recommendations were not possible for several preventive
health services for women, such as for women's cancer
screening and contraception.
Studies that assess the extent to which female ED patients
need cancer screening and contraceptive services would
help inform policy makers about which services should be
offered. However, an appreciation of what ED patients
know about the cancer screening and contraceptive meth-
ods being offered is also required. If female ED patients do
not have a working knowledge of what is being offered to
them, they might be less likely to accept it and be less able
to correctly answer questions about their need for it. As a
result of knowledge deficits, a misunderstanding of the
extent of the need for cancer screening and contraceptive
services by women who visit EDs could occur and incor-
rect policy decisions might be made. By appreciating the
extent of female ED patient's knowledge about women's
cancer screening and contraceptive methods, identifying
which women might have lesser knowledge, discovering
which methods in particular women have lesser knowl-
edge about, and understanding what aspects about these
methods they have reduced knowledge about could direct
future educational endeavors and interventions to
encourage women to receive them, whether in the ED or
in follow-up.
Patient knowledge about cancer screening and contracep-
tion during a clinical encounter is also crucial for ED cli-
nicians to obtain an accurate medical history, to direct
appropriate medical interventions, and to make recom-
mendations for such services. Unfortunately for the
patient and the health care provider, female patients'
knowledge about the purpose of and their prior usage of
women's cancer screening and contraception is often lim-
ited or incomplete [8-16]. For example, in a survey on
Papanicolaou (Pap) smear knowledge, Ideström et al.
observed that 95% of women surveyed believed they
knew the purpose of Pap screening, but only 62% could
correctly identify the type of cancer it tested [9]. In a 2004
study by Lyons et al. of women undergoing pelvic exami-
nations in the ED, 74% mistakenly believed that they had
undergone a Pap smear [8]. Of the patients interviewed,
81.5% believed that they knew the purpose of a Pap
smear; however, only 26% of those correctly indicated a
Pap smear is for cervical cancer. In several studies, a lack
of utilization of women's cancer screening or contracep-
tive methods is associated with knowledge deficits about
these methods, and vice versa [14,17-24]. For example, in
a 2000 study of Korean-American women by Han et al.,
those with less knowledge about the purpose of clinical
breast exams were significantly less likely to have had one
[18]. In a study of socio-economically disadvantaged
women in the South Bronx by Carter et al., low knowledge
about women's cancer screening was associated with
underutilization of Pap smears, breast self-exams, and
clinical breast exams [19].
By delineating knowledge deficits about women's cancer
screening and contraceptive methods according to the
demographic and other factors in the population to which
they serve, ED clinicians can identify groups of women
who might benefit from expanded information and teach-
ing. ED clinicians can also anticipate which patients might
be less able to provide accurate histories of their usage of
these methods. Studies in other settings have demon-
strated that readily identifiable demographic factors, such
as education [14,15,21,22,25-27], marital status
[20,21,28], employment [21,26], type or status of insur-
ance [27,29], race or ethnicity [29,30], and age
[9,11,22,26,27] are associated with greater or lesser
women's cancer screening and contraceptive knowledge,
depending upon the population and method studied. ED
clinicians who are conscious of potential indictors of
reduced knowledge among certain groups of patients
might be able to offer more in-depth teaching to improve
patient utilization of women's cancer screening and con-
traceptive methods.
Therefore, the goals of this study were (1) to ascertain the
knowledge of 18–55 year-old women being treated in an
ED on the applicability, purpose, and recommended tim-
ing for three women's cancer screening methods: Pap
smears, breast self-examinations, and mammograms; and
three contraceptive methods: birth control, emergency
contraception, and condoms; and (2) to determine if
readily identifiable demographic factors (age, race/ethnic-
ity, and insurance status) as well as usage of these meth-
ods are associated with greater or lesser knowledge about
these women's cancer screening and contraceptive meth-
ods.BMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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Methods
Study design
The study was a survey of 18–55-year-old, English-speak-
ing, female ED patients using a self-administered, written,
anonymous, multiple choice, single-best answer ques-
tionnaire that was developed by the study authors. The
hospital institutional review board approved the study as
exempt from review and written informed consent.
Study setting
We conducted the study at an urban, Level I trauma, adult,
academic, tertiary referral center, northeastern US ED with
a catchment area of approximately 1.5 million people. In
fiscal year 2002, there were 73,672 adult patient visits,
and 49.0% of these were by women. Of these visits by
women, 24,087 (66.7%) were by women between the
ages of 18–55. Figure 1 shows the demographic profiles of
these women.
Survey design
We searched MEDLINE for surveys on women's health
preventive topics and reviewed their contents, styles of
questions, and survey methods. If a survey was not
included in an article, we contacted the articles' authors
and requested a copy. Fourteen surveys on various health
topics were available for our review and four covered the
topics in our study [28,31-43]. We chose six topics for our
survey and created questions patterned on the styles used
in the surveys from our review. These six topics were on
women's cancer screening and contraceptive methods for
which ED-based interventions might be possible---such as
providing, making referrals for, or giving educational
materials about these methods from the ED. The topics
comprised three women's cancer screening methods: Pap
smears, breast self-examinations, and mammograms; and
three contraceptive methods: birth control, emergency
contraception, and condoms. The survey included demo-
graphic and health history questions, as well as questions
on the respondents' usage of and knowledge on these six
methods. The cancer screening and contraceptive method
knowledge questions asked the applicability, purpose,
and recommended intervals for each of these methods.
For example, the questions asked, "Who should have a
Pap smear/Pap test?" (applicability), "Why do you think a
Pap smear/Pap test is done?" (purpose), and "How often
should most people go for a Pap smear/Pap test (unless
otherwise directed by a doctor)?" (recommended inter-
vals). A summary of the cancer screening and contracep-
tive knowledge questions are in Table three. The reading
level of the entire survey was at a Flesch-Kincaid grade
level of 5.4 (Microsoft Word, Redmond, WA).
We created a draft questionnaire and pilot tested it in June
2002 on a convenience sample of twenty female patients
from the ambulatory care section of the ED. Using a
standardized script, we interviewed these women after
they completed the survey. The interview consisted of a
brief cognitive assessment on randomly selected ques-
tions from the questionnaire, a review of potentially sen-
sitive questions, and an analysis of mis-marked responses.
We also solicited feedback on their opinions, impressions,
and reactions to the questionnaire. Each of these women
received $20 for participation in this pilot test. We revised
the survey based upon their comments and our observa-
tions, e.g., poorly worded questions were rewritten, terms
of confusion clarified, typographical errors corrected, etc.
The final survey germane to this analysis included 36 mul-
tiple choice questions: six demographic questions, four-
teen health history questions (cancer screening, sexual,
contraceptive, and pregnancy history), and three knowl-
edge-based questions on the applicability, purpose, and
recommended intervals for each of the six topics (except
emergency contraception, which had one question that
assessed knowledge about the concept and purpose of
emergency contraception).
Survey administration
We chose to survey 18–55-year-old women, as we sus-
pected that older women might have different health con-
cerns (e.g. menopause) and were less likely to use the
contraceptive methods mentioned in the survey. Women
were excluded if they could not read or write in English;
were being evaluated in the critical care, psychiatric sec-
tion, or alcohol abuse holding areas of the ED; were not
awake; or could not physically complete the form. Other-
wise, any awake female patient present in the non-psychi-
atric care, non-alcohol abuse holding areas, and non-
critical care area of the ED during the times data was col-
lected was approached and asked to be in the survey if
they met the age and English-speaking inclusion criteria.
Patients were apprised of the nature, content, and purpose
of the study and were asked to give their verbal consent to
participate. Since this was the initial survey on this subject
we had prepared, we limited the study to English-speaking
patients as a pilot of the instrument for future studies that
involve a more inclusive population of women. Each par-
ticipant who completed the survey received a $2 gift card
to a local pharmacy.
Research assistants and trained volunteers administered
the survey in three two-month blocks that included 66
eight-hour shifts in July-August 2002, 32 four-hour shifts
in October-November 2002, and 32 four-hour shifts in
April-May 2003. Training of the research assistants and
volunteers consisted of two-hour didactic sessions with
the study authors on how to approach ED patients, which
patients to approach, how to recognize exclusion criteria,
and how to present patients with the self-administered
survey. We purposely sampled three different seasons to
avoid unknown time-dependent factors that might influ-BMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
Page 4 of 13
(page number not for citation purposes)
Enrollment diagram Figure 1
Enrollment diagram.
Women age 18-55 visiting the ED in 
fiscal year 2002  
(n = 24,087)
Women age 18-55 visiting the ED 
during the study period  
(n = 12044)
Women age 18-55 present during 
survey shifts  
(n = 2189, 18.2% [17.5-18.9%])
Women age 18-55 approached  
(n = 1197, 54.7% [52.6-56.8%])
Study eligible women age 18-55  
(n = 1100)
Women who agreed to  
enroll in study  
(n = 769, 69.9% [67.1-72.7%])
AGE
 18-25: 24.9% [24.4-25.5%]
 26-35: 25.7% [25.1-26.2%]
 36-45: 29.0% [28.4-29.6%]
 46-55: 20.4% [19.9-20.9%]
INSURANCE
 Governmental: 44.3% [43.6-44.9%] 
 Private: 38.2% [37.6-38.8%] 
 None: 17.5% [17.0-18.0%] 
RACE/ETHNICITY 
 Black/African American:  10.4% [10.0-10.8%] 
 Hispanic/Latino: 19.6% [19.1-20.1%] 
 White: 67.7% [66.4-67.6%] 
 Other:  2.9% [2.7-3.1%] 
Women Approached 
 18-25: 350 (29.6% [27.0-32.3%]) 
 26-35: 339 (28.6% [26.1-31.3%]) 
 36-45: 320 (27.0% [24.5-30.0%]) 
 46-55: 175 (14.8% [12.8-16.9%]) 
Excluded because of an inability to 
speak/understand English  
(n = 97)
Refusals: n = 331 (30.1% [27.4-32.9%]) 
 Bothered by nature of questions: 0.6% 
 In pain: 37.5% 
 No time: 4.2% 
 Not interested: 26.0% 
 Too tired: 10.6% 
 Too long: 2.7% 
 Other: 18.4%
Women Enrolled  
 18-25: 261 (34.3% [30.9-37.8%]) 
 26-35: 211 (27.7% [24.6-31.1%]) 
 36-45: 183 (24.0% [21.1-27.2%]) 
 46-55: 106 (13.9% [11.5-16.6%]) BMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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ence the pattern of ED visits. The data collection shifts
were scheduled to reflect the time-dependent influx of
patients to our ED. In brief, we structured our survey
administration such that 25% of the shifts were between
7 a.m. and 11 a.m., 50% between 11 a.m. and 11 p.m.,
and 25% from 11 p.m. to 7 a.m. This ED's daily volume is
essentially the same each day of the week. To reflect this
pattern of patient visits, we conducted our survey so that
each day of the week was represented equally.
Data analysis
Two research assistants independently entered the data
into separate Epi Info 2002 (Centers for Disease Control
and Prevention, Atlanta, GA) databases. The research
assistants completed a self-guided tutorial on Epi Info
2002 [44] and were trained by the primary author on how
to review the data forms prior to conducting the data
entry. The two independent databases were compared
using the data compare feature of Epi Info 2002 for every
entry. Errors were corrected to create a final database. We
transferred the final database for analysis into Stata 8.2
(Stata Corporation, College Station, TX) using Stat/
Transfer6 (Circle Systems, Seattle, WA). We tabulated the
frequency of responses to each of the questions and calcu-
lated 95% confidence intervals for estimates when appli-
cable.
For the logistic regression analyses, we created binary out-
come variables for each of the women's cancer screening
and contraceptive knowledge questions. These outcome
variables were defined as correct vs. incorrect responses to
each of the knowledge questions. Responses of "I am not
really sure" were considered incorrect responses for this
analysis. We further created a composite binary outcome
variable that was composed of having responded correctly
vs. incorrectly to all answers for a given topic. The analyses
focused primarily upon these composite outcome varia-
bles. We conducted univariable logistic regression analy-
ses using the log odds of the probability of correctly
answering the questions as the outcome variable, and age
group, race/ethnicity, private medical insurance, and
recent/ever usage of a given cancer screening or contracep-
tive method as the independent variables. We then cre-
ated multivariable logistic regression models using all of
these independent variables. Independent variables were
considered to be significantly related to the outcome at
the α = 0.05 level of significance.
Results
Study enrollment and participant demographics
Of 1,197 women approached to participate in the survey,
97 were ineligible because of an inability to communicate
in English. Of the remaining 1,100 women, 769 (69.9%)
completed all or part of the questionnaire. These 769 par-
ticipants comprised 35.1% of the women present in the
ED when the survey was administered. The Figure shows
the enrollment patterns for the study. Participation was
slightly higher among the youngest age group. The major-
ity of non-participating women reported pain as their pri-
mary reason for declining (37.5%); only a few were
bothered by the description of the survey's content
(0.6%). Participants who answered any part of the survey
were included in this analysis. The number of responses to
the questions decreased in relation to the length of the
survey. Patients who did not complete the questionnaire
had left the ED prior to its completion. The number of
respondents for each question is provided throughout the
tables.
Table 1 provides the respondent demographic profiles.
Most of the women were under age 35, white, single
(never married and no partner), Catholic, and had private
medical insurance. Compared to all 18–55-year-old
women visiting the ED in fiscal year 2002, the sample
included slightly more 18–25-year-olds and slightly fewer
46–55-year-olds (Figure and Table 1). Compared to all
18–55-year-old women presenting to the ED in 2002,
more respondents had private medical insurance. In com-
parison, fewer were white or Hispanic/Latina, about the
same percentage were black, while more were of other
racial/ethnic groups.
Health history
Table 2 shows the responses to the cancer screening, sex-
ual, contraceptive, and pregnancy history questions.
Although a majority of women reported having a Pap
smear within the past year (69.1%), fewer had examined
their own breasts within the past month (45.5%), used
any form of birth control (26.3%), always used condoms
(16.8%) or ever used emergency contraception (9.3%).
Among 45–55-year-old women who had not undergone a
mastectomy, 65.7% had a mammogram within the prior
year. (Participant's age group but not actual age was
requested in the survey.) Among the entire sample, most
women (74.3%) reporting having had intercourse with a
man within the past month, and the majority of respond-
ents (69.9%) had been pregnant at least once in their life-
time.
Women's cancer screening and contraceptive knowledge 
questions
Table 3 provides a concise summary of each of the
women's cancer screening and contraceptive knowledge
questions and the percentage of women who answered
the questions correctly. The questions answered correctly
most often were about condom use and the question
answered correctly the least often was about emergency
contraception. For the five topics that had three questions
each for that topic (who, why, and how often), the per-
centage of women who correctly answered all three ques-BMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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tions for a given topic was lower than the percentage of
women who correctly answered any one of the three ques-
tions for that topic. The percentage of women correctly
answering the three questions within a topic was similar,
except in three cases. Although most women understood
the purpose of having a mammogram (86.7%), fewer
could identify that "women over age 40 and/or those
women instructed by their doctor" should have a mam-
mogram (50.3%) or that mammograms are typically
scheduled every five years (62.1%). Likewise, compared to
other questions within their respective topics, fewer
women could identify that breast self-examinations are
recommended monthly (82.5%) and fewer understood
that birth control pills are taken only by women (87.2%).
Logistic regression analyses
Table 4 provides the results of the univariable logistic
regression analyses that compared ability to answer the
cancer screening and contraceptive knowledge questions
correctly by age group, racial/ethnic group, recent or cur-
rent use of a particular cancer screening or contraceptive
method, and by whether or not the respondent had pri-
vate medical insurance. In these analyses, older age was a
statistically significant predictor of correctly answering all
questions about Pap smears and mammograms. Racial/
ethnic group was a statistically significant predictor of Pap
smear and mammogram knowledge, and was marginally
predictive of breast self-examination and birth control pill
knowledge. For example, compared to white women,
other race women had a 0.28, black women had a 0.31,
and Hispanic/Latina women had a 0.27 lesser odds of
being able to answer all Pap smear questions correctly.
Having private medical insurance was a statistically signif-
icant predictor for all cancer screening and contraceptive
knowledge questions. For example, women with private
medical insurance had a 3.14 greater odds of answering
Table 1: Demographic profile of survey respondents
%
AGE GROUP
n = 761 18–25 34.3
26–35 27.7
36–45 24.2
46–55 13.9
RACIAL/ETHNIC SELF-IDENTITY
n = 754 American Indian/Native American 5.3
Asian/Pacific Islander 1.9
Black/African-American 12.1
Hispanic/Latina 15.8
White 58.2
Bi/Multiracial 6.0
Other 0.8
MARITAL/RELATIONSHIP STATUS
n = 767 Single 42.5
Married 29.5
Divorced/Separated/Annulled 14.3
Male partner 11.0
Female Partner 1.0
Widowed 1.7
RELIGIOUS IDENTITY
n = 759 Buddhist 1.5
Catholic 50.2
Hindu 0.1
Jewish 0.9
Muslim 1.1
Protestant 25.4
No religious preference 16.9
Other 4.0
HEALTH INSURANCE
n = 759 Private 50.9
Governmental 32.8
No Insurance 16.3BMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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all Pap smear questions correctly. Recent or current usage
of a cancer screening or contraceptive method (ever usage
for emergency contraception) was a statistically signifi-
cant predictor of correctly answering all questions except
condom usage. For example, compared to women who
have not had a Pap smear in the last year, those who had
Table 2: Health history
SCREENING HISTORY
n%
Last PAP smear (no hysterectomy) 679 
Within past year 69.1
>1 year ago 24.2
Never 6.8
Last mammogram (all women, no mastectomy) 731
Within past year 22.9
>1 year ago 14.5
Never 6.27
Last mammogram (age 45-55, no mastectomy) 102
Within past year 65.7
>1 year ago 29.4
Never 4.9
Last BSE exam (no mastectomy) 755
Within past year 45.5
>1 year ago 31.5
Never 23.0
SEXUAL HISTORY
Last time having sex with a man 737
< 1 week 48.2
< 1 month 22.1
< 6 months 9.9
< 1 year 4.9
> 1 year 9.5
Never 5.4
Frequency of condom use 739
No intercourse/no sex with men 8.1
Never 45.7
Sometimes 17.1
Most of the time 13.7
Every time 15.4
CONTRACEPTIVE HISTORY
Yes No
Currently taking BCPs 758 17.8 82.2
Using other BC 749 11.6 88.4
Had a BTL 750 25.6 72.6
Had a hysterectomy 752 10.1 89.9
Use any form of BC
Ever used EC 752 9.3 90.7
Ever had an abortion 748 23.7 76.3
PREGNANCY HISTORY
Yes No Not Sure
Currently pregnant 759 26.0 93.0 4.6
Ever pregnant 760 69.9 30.1
Number of Times Pregnant 758
Never 29.0
1 13.5
2 17.3
3 17.4
4 12.1
> 4 10.7
KEY TO ABREVIATIONS
PAP: Papanicolaou BC(Ps): Birth Control (Pills) EC: Emergency Contraception
BSE: Breast Self Exam BTL: Bilateral Tubal LigationBMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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a Pap smear had a 1.71 greater odds answering all Pap
smear questions correctly.
Table 5 displays the results of the multivariable logistic
regression analyses. In these analyses, age group, racial/
ethnic group, having private medical insurance, and cur-
rent, recent or ever (for emergency contraception only)
use of the cancer screening or contraceptive methods were
used as covariates in the models. In the regression models
employing the composite outcome of correctly answering
all questions on a given topic, older age remained associ-
ated with greater Pap smear and mammogram knowl-
edge; being of white race was associated with greater Pap
smear knowledge and was generally associated with
greater mammogram knowledge; being Hispanic/Latina
was associated with lesser Pap smear, breast self-exam,
mammogram, and condom knowledge; having private
medical insurance was associated with greater knowledge
for all six topics; and recent or current usage of a given
screening or contraceptive method was associated with
greater Pap smear, breast self-examination, and birth con-
trol pill knowledge, and ever use of emergency contracep-
tion was associated with greater emergency contraception
knowledge.
Discussion
For these 18–55-year-old women visiting the ED, we
observed several interesting patterns of women's cancer
screening and contraceptive knowledge. We noted areas in
which knowledge of the applicability, purpose, and rec-
ommended usage intervals of these six cancer screening
and contraceptive modalities was strong or poor, as well
as groups with greater or lower knowledge levels. These
findings should help the health care providers identify
patients who might require more extensive discussions to
evaluate the patient's prior usage of these methods. The
findings also provide a cautionary note to researchers and
clinicians who intend to assess the need for preventive
health services for women in EDs. Female ED patients
who do not have private health care insurance, those who
do not use these methods, and perhaps Hispanic/Latina
patients might not understand the applicability, purpose,
and recommended intervals of these six cancer screening
and contraceptive methods, and therefore might inaccu-
Table 3: Respondents answering cancer screening and contraceptive knowledge questions correctly
n % correct 95% CI
PAP SMEAR CORRECT ANSWERS
Who should get a Pap smear? Adult women 729 72.7 69.3–75.9
Why is a Pap smear performed? Cervical cancer screening 724 73.2 69.8–76.4
How often do most people undergo a Pap smear?* Yearly 724 74.0 70.0–77.2
All correct answers 717 52.9 49.1–56.6
BREAST SELF-EXAM
Who should examine their own breasts? Adult women 728 91.4 89.1–93.3
Why should a woman examine her own breasts? Breast cancer screening 726 94.2 92.3–95.8
How often should a woman examine her own breasts? Monthly 725 82.5 79.5–85.2
All correct answers 721 78.5 75.3–81.4
MAMMOGRAM
Who should have a mammogram? Age 40+/advised by doctor 722 50.3 46.7–54.0
Why should a woman have a mammogram? Breast cancer screening 723 86.7 84.0–89.1
How often should a woman typically have a mammogram?* Every 5 years 718 62.1 58.5–65.7
All correct answers 718 35.4 31.9–40.0
BIRTH CONTROL PILLS
Who may take birth control pills? Only women 717 87.2 84.5–89.5
Why might someone take birth control pills? Prevent pregnancy 718 95.8 94.4–97.2
How often should someone take birth control pills? Daily 717 91.9 90.0–93.8
All correct answers 713 82.5 79.5–85.2
EMERGENCY CONTRACEPTION
Can birth control pills taken after sex prevent pregnancy? Yes 713 25.0 21.8–28.3
CONDOMS
Who should use condoms during sex? Anyone having sex 709 92.0 89.7–93.6
Why should someone use condoms during sex? Prevent pregnancy/infection 707 96.5 94.8–97.7
How often should someone use condoms? Always with sex 706 92.9 90.8–94.7
All correct answers 700 87.9 85.2–90.1
n.b. All questions are paraphrased here for conciseness.
*"Unless otherwise directed by a doctor" stated for these questionsB
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) Table 4: Univariable logistic regression analyses
AGE RACIAL/ETHNIC GROUP INSURANCE HEALTH HISTORY
OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs)
PAP SMEARS
26–35 36–45 46–55 Other Black Hispanic Private Pap < 1 year
Who 1.64 (1.03–2.48) 1.53 (1.00–2.36) 2.14 (1.23–3.72) 0.36 (0.22–0.58) 0.38 (0.23–0.64) 0.24 (0.16–0.38) 2.57 (1.82–3.61) 1.46 (1.03–2.06)
Why 1.80 (1.19–2.73) 1.99 (1.28–3.10) 3.05 (1.68–5.51) 0.47 (0.29–0.76) 0.47 (0.28–0.78) 0.36 (0.23–0.56) 3.40 (2.38–4.86) 1.54 (1.09–2.18)
When 1.72 (1.13–2.61) 1.98 (1.26–3.11) 2.61 (1.46–4.68) 0.28 (0.17–0.46) 0.25 (0.15–0.41) 0.42 (0.26–0.68) 3.07 (2.15–4.39) 1.41 (0.99–2.01)
All correct 1.85 (1.27–2.71) 2.33 (1.56–3.48) 3.41 (2.08–5.60) 0.28 (0.18–0.46) 0.31 (0.19–0.51) 0.27 (0.17–0.43) 3.14 (2.31–4.27) 1.71 (1.24–2.36)
BREAST SELF-EXAMS
26–35 36–45 46–55 Other Black Hispanic Private BSE < 1 month
Who 0.90 (0.45–1.78) 0.76 (0.38–1.51) 0.86 (0.38–1.97) 0.72 (0.31–1.63) 0.74 (0.31–1.77) 0.33 (0.18–0.63) 3.66 (2.01–6.67) 2.00 (1.43–2.79)
Why 0.74 (0.32–1.71) 0.57 (0.25–1.30) 0.91 (0.31–2.68) 0.42 (0.17–1.07) 0.53 (0.19–1.51) 0.28 (0.13–0.62) 3.23 (1.55–6.74) 1.09 (0.72–1.63)
When 1.36 (0.85–2.18) 1.94 (1.13–3.32) 1.97 (1.02–3.79) 0.50 (0.28–0.87) 0.45 (0.25–0.80) 0.41 (0.24–0.68) 2.61 (1.74–3.93) 2.03 (1.59–2.60)
All correct 1.45 (0.92–2.28) 1.57 (0.97–2.55) 1.45 (0.82–2.55) 0.64 (0.37–1.09) 0.55 (0.32–0.95) 0.39 (0.24–0.62) 2.66 (1.82–3.87) 1.95 (1.56–2.46)
MAMMOGRAMS
26–35 36–45 46–55 Other Black Hispanic Private Mammo < 1 year
Who 2.15 (1.47–3.15) 2.19 (1.47–3.27) 2.08 (1.30–3.31) 0.52 (0.33–0.82) 0.67 (0.42–1.08) 0.56 (0.37–0.86) 2.72 (1.76–4.20) 0.96 (0.67–1.37)
Why 2.46 (1.38–4.38) 1.90 (1.07–3.35) 2.88 (1.31–6.32) 0.36 (0.20–0.65) 0.60 (0.29–1.24) 0.34 (0.19–0.60) 3.66 (2.01–6.66) 0.71 (0.40–1.29)
When 1.39 (0.95–2.02) 2.54 (1.67–3.88) 4.63 (2.63–8.16) 0.37 (0.23–0.58) 0.59 (0.36–0.96) 0.44 (0.29–0.67) 3.59 (2.33–5.54) 0.37 (0.25–0.57)
All correct 1.68 (1.12–2.53) 2.21 (1.45–3.37) 2.54 (1.56–4.12) 0.36 (0.21–0.61) 0.58 (0.35–0.97) 0.38 (0.23–0.61) 3.68 (2.21–6.11) 0.60 (0.42–0.86)
BIRTH CONTROL 
PILLS
26–35 36–45 46–55 Other Black Hispanic Private BCP users (cur.)
Who 0.49 (0.26–0.92) 0.28 (0.15–5.53) 0.51 (0.24–1.08) 0.41 (0.23–0.75) 0.46 (0.24–0.88) 0.72 (0.38–1.38) 2.75 (1.71–4.44) 0.29 (0.13–0.69)
Why 0.19 (0.05–0.69) 0.19 (0.05–0.71) 0.30 (0.07–1.38) 0.45 (0.16–1.23) 0.78 (0.22–2.84) 0.63 (0.22–1.83) 4.83 (1.81–12.91) infinite
When 0.61 (0.30–1.24) 0.69 (0.32–1.47) 0.75 (0.31–1.85) 0.60 (0.27–1.33) 0.50 (0.22–1.11) 0.46 (0.23–0.94) 2.28 (1.27–4.09) 0.31 (0.11–0.86)
All correct 0.64 (0.38–1.09) 0.45 (0.27–0.77) 0.57 (0.31–1.06) 0.45 (0.26–0.78) 0.47 (0.27–0.84) 0.65 (0.38–1.14) 2.74 (1.81–4.16) 0.27 (0.13–0.57)
EMERGENCY 
CONTRACEPTION
26–35 36–45 46–55 Other Black Hispanic Private EC users
EC possible 0.62 (0.40–0.96) 0.76 (0.48–1.19) 0.74 (0.43–1.26) 0.89 (0.53–1.51) 1.41 (0.84–2.36) 1.03 (0.63–1.66) 1.59 (1.13–2.24) 0.38 (0.22–0.64)
CONDOMS Condom use
26–35 36–45 46–55 Other Black Hispanic Private Sometimes Often Always
Who 0.62 (0.30–1.30) 0.56 (0.26–1.18) 0.61 (0.26–1.46) 0.67 (0.30–1.47) 1.36 (0.46–4.01) 0.56 (0.27–1.14) 3.16 (1.68–5.93) 1.70 (0.72–3.97) 1.92 (0.72–5.08) 2.17 (0.82–5.73)
Why 0.33 (0.08–1.30) 0.21 (0.06–0.80) 0.24 (0.06–1.01) 0.30 (0.10–0.89) 0.52 (0.13–1.99) 0.41 (0.13–1.28) 2.45 (1.00–6.04) 1.16 (0.37–3.68) 1.88 (0.41–8.53) 2.09 (0.46–9.50)
When 0.77 (0.34–1.75) 0.35 (0.17–0.74) 1.67(0.46–6.06) 0.44 (0.19–1.02) 0.85 (0.28–2.57) 0.29 (0.14–.59) 2.37 (1.26–4.47) 1.08 (0.49–2.38) 1.10 (0.46–2.64) 3.01 (0.89–10.17)
All correct 0.60 (0.32–1.09) 0.43 (0.24–0.79) 0.73 (0.33–1.58) 0.68 (0.35–1.33) 1.29 (0.53–3.16) 0.42 (0.24–0.74) 2.12 (1.31–3.42) 1.09 (0.58–2.05) 1.68 (0.76–3.71) 1.78 (0.72–4.41)
REFERENCE GROUPS KEY TO ABREVIATIONS
Age: 18–25 Health History Pap: Pap Smear > 1 year BC Users: Non-current BCP Users
Racial/Ethnic Group: 
White
BSE: BSE > 1 month EC Users: Never used EC PAP: Papanicolaou BCP: Birth Control Pills
Insurance: Non-private Mammogram: Mammogram > 1 year Condom Use: Never use condoms BSE: Breast Self Exam EC: Emergency ContraceptionB
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Table 5: Multivariable logistic regression analyses
AGE RACIAL/ETHNIC GROUP INSURANCE HEALTH HISTORY
n OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs) OR (95% CIs)
PAP SMEARS
26–35 36–45 46–55 Other Black Hispanic Private ins Pap < 1 year
Who 702 1.70 (1.09–2.66) 1.44 (0.90–2.30) 2.01 (1.09–3.70) 0.47 (0.28–0.78) 0.42 (0.24–0.71) 0.30 (0.19–0.49) 1.91 (1.32–2.76) 1.51 (1.04–2.21)
Why 699 1.88 (1.21–2.92) 2.12 (1.30–3.44) 2.96 (1.56–5.62) 0.68 (0.40–1.14) 0.54 (0.32–0.94) 0.53 (0.33–0.87) 2.99 (2.04–4.37) 1.67 (1.14–2.44)
When 698 1.88 (1.20–2.95) 2.18 (1.33–3.59) 2.95 (1.52–5.71) 0.38 (0.23–0.64) 0.29 (0.17–0.49) 0.60 (0.36–1.00) 2.32 (1.57–3.42) 1.46 (0.98–2.16)
All correct 694 2.11 (1.40–3.18) 2.53 (1.63–3.94) 3.77 (2.16–6.57) 0.39 (0.23–0.64) 0.34 (0.20–0.57) 0.37 (0.23–0.61) 2.35 (1.68–3.29) 1.83 (1.27–2.62)
BREAST SELF-EXAMS
26–35 36–45 46–55 Other Black Hispanic Private ins BSE < 1 month
Who 702 0.84 (0.41–1.70) 0.63 (0.29–1.35) 0.57 (0.23–1.43) 1.12 (0.45–2.77) 0.91 (0.37–2.24) 0.48 (0.24–0.96) 3.32 (1.72–6.42) 1.91 (1.34–2.74)
Why 702 0.66 (0.27–1.58) 0.53 (0.21–1.34) 0.77 (0.23–2.60) 0.60 (0.22–1.67) 0.61 (0.21–1.81) 0.32 (0.14–0.76) 2.76 (1.24–6.16) 1.07 (0.69–1.66)
When 699 1.26 (0.76–3.44) 1.28 (0.64–2.56) 0.56 (0.31–1.03) 0.56 (0.31–1.03) 0.50 (0.27–0.93) 0.61 (0.35–1.06) 2.07 (1.32–3.23) 1.90 (1.46–2.47)
All correct 698 1.37 (0.85–2.21) 1.31 (0.78–2.23) 0.99 (0.54–1.83) 0.81 (0.45–1.45) 0.63 (0.35–1.13) 0.51 (0.31–0.85) 2.28 (1.51–3.43) 1.89 (1.48–2.41)
MAMMOGRAMS
26–35 36–45 46–55 Other Black Hispanic Private ins Mammo < 1 year
Who 677 2.18 (1.47–3.25) 2.32 (1.49–3.63) 2.16 (1.23–3.77) 0.67 (0.41–1.09) 0.79 (0.48–1.33) 0.75 (0.47–1.18) 1.84 (1.33–2.56) 1.42 (0.92–2.20)
Why 678 2.25 (1.23–4.14) 2.13 (1.06–4.31) 2.58 (0.99–6.74) 0.43 (0.22–0.84) 0.67 (0.31–1.44) 0.48 (0.25–0.91) 2.68 (1.56–4.61) 1.22 (0.59–2.51)
When 674 1.41 (0.94–2.11) 2.58 (1.59–4.19) 3.42 (1.77–6.64) 0.45 (0.27–0.75) 0.68 (0.39–1.17) 0.61 (0.38–0.98) 2.22 (1.57–3.14) 0.71 (0.43–1.18)
All correct 673 1.77 (1.15–2.71) 2.10 (1.31.3.36) 1.88 (1.05–3.37) 0.53 (0.31–0.92) 0.69 (0.40–1.19) 0.51 (0.30–0.85) 2.21 (1.56–3.12) 0.88 (0.56–1.37)
BIRTH CONTROL PILLS
26–35 36–45 46–55 Other Black Hispanic Private ins BC users
Who 694 0.48 (0.25–0.94) 0.33 (0.17–0.63) 0.55 (0.24–1.26) 0.55 (0.29–1.06) 0.53 (0.27–1.04) 0.84 (0.41–1.69) 2.49 (1.47–4.20) 0.52 (0.21–1.30)
Why 569 0.20 (0.06–0.75) 0.36 (0.09–1.48) 0.28 (0.06–1.30) 0.67 (0.23–1.93) 0.95 (0.25–3.60) 0.84 (0.27–2.62) 5.08 (1.66–15.57) infinity
When 696 0.64 (0.31–1.31) 0.75 (0.34–1.67) 0.75 (0.30–1.88) 0.77 (0.34–1.77) 0.58 (0.25–1.33) 0.54 (0.26–1.14) 1.90 (1.03–3.53) 0.41 (0.14–1.19)
All correct 692 0.66 (0.38–1.13) 0.51 (0.29–0.90) 0.60 (0.31–1.18) 0.62 (0.34–1.10) 0.56 (0.31–1.03) 0.74 (1.52–3.73) 2.38 (1.52–3.73) 0.42 (0.19–0.91)
EMERGENCY 
CONTRACEPTION
26–35 36–45 46–55 Other Black Hispanic Private ins EC users
EC possible 688 0.61 (0.39–0.96) 0.76 (0.48–1.20) 0.69 (0.40–1.19) 1.08 (0.62–1.88) 1.63 (0.94–2.81) 1.20 (0.72–2.01) 1.78 (1.22–2.59) 0.36 (0.21–0.63)
CONDOMS Condom use
26–35 36–45 46–55 Other Black Hispanic Private ins Sometimes Often Always
Who 629 0.74 (0.32–1.73) 0.78 (0.30–2.02) 0.47 (0.17–1.30) 0.70 (0.29–1.71) 1.76 (0.50–6.22) 0.76 (0.32–1.82) 3.23 (1.52–6.85) 1.62 (0.63–4.17) 1.43 (0.51–4.01) 1.71 (0.62–4.72)
Why 628 0.26 (0.05–1.36) 0.22 (0.04–1.19) 0.14 (0.02–0.84) 0.22 (0.06–0.84) 0.34 (0.08–1.52) 0.34 (0.08–1.40) 1.95 (0.64–5.95) 0.72 (0.21–2.53) 0.91 (0.18–4.67) 1.31 (0.27–6.41)
When 627 0.83 (0.33–2.08) 0.30 (0.12–0.72) 1.01 (0.25–4.00) 0.49 (0.20–1.25) 1.32 (0.48–3.59) 0.41 (0.21–0.80) 1.94 (1.11–3.39) 1.07 (0.54–2.11) 1.25 (0.54–2.90) 1.53 (0.67–3.50)
All correct 624 0.67 (0.34–1.34) 0.41 (0.20–0.86) 0.63 (0.26–1.56) 0.63 (0.30–1.32) 1.32 (0.48–3.59) 0.41 (0.21–0.80) 1.94 (1.11–3.39) 1.07 (0.54–2.11) 1.25 (0.54–2.90) 1.53 (0.67–3.50)
REFERENCE GROUPS KEY TO ABREVIATIONS
Age: 18–25 Health History Pap: Pap Smear > 1 year BC Users: Non-current BCP Users
Racial/Ethnic Group: White BSE: BSE > 1 month EC Users: Never used EC PAP: Papanicolaou BCP: Birth Control Pills
Insurance: Non-private Mammogram: Mammogram > 1 year Condom Use: Never use condoms BSE: Breast Self Exam EC: Emergency ContraceptionBMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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rately relate their need for or prior use of them. Further,
these women might benefit from expanded discussions
with ED providers in initiatives that try to increase patient
utilization of these methods.
Knowledge about the six women's cancer screening and
contraceptive methods varied across topics, and for some
methods, knowledge varied within topics. For example,
knowledge about the purpose and applicability of breast
self-examinations was high; however, fewer women knew
the recommended intervals. Knowledge of who may take
birth control pills was lower than why and how often they
should be taken. Perhaps recent press regarding efforts to
produce a male birth control pill may have confused par-
ticipants. Lower knowledge of how often women should
undergo mammograms and who should get them may be
a consequence of conflicting messages from public health
groups (and perhaps health care providers) on this sub-
ject. Knowledge of emergency contraception was quite
poor, a finding that is supported elsewhere [12,13,16].
The findings from this study demonstrate that knowledge
across and within these topics is variable and helps to
identify areas of reduced knowledge. This variability
needs to be accounted for when assessing patient under-
standing of various women's cancer screening and contra-
ceptive methods and in the planning of interventions to
increase usage of these methods.
Two factors, having private medical insurance and recent
or current usage of certain women's cancer screening and
contraceptive methods, were statistically significant pre-
dictors of knowledge in the multivariable logistic regres-
sion models. Patients who had governmental (Medicare,
Medicaid, or both) medical insurance and patients who
did not have any type of insurance demonstrated lesser
cancer screening and contraceptive knowledge compared
to those with private medical insurance. Our findings are
supported by results from other studies [14,17-23,27,29].
For example, in Takakuwa et al.'s study, having private
medical insurance was positively associated with greater
knowledge of preventive behaviors regarding breast can-
cer [29], and in Han et al.'s study, women who had never
received a clinical breast exam exhibited significantly
lower knowledge of clinical breast exams [18]. Knowledge
was not perfectly associated with consistent usage, how-
ever. Most women understood well the who, when, and
how often condoms should be used – although few used
them consistently.
It is likely that having private medical insurance reflects
higher socioeconomic status, which is associated with
greater educational opportunities and enhanced contact
with medical providers. Although not addressed in this
study, other studies have shown that having a primary
care or obstetrician/gynecologist provider and having
recently visited one is associated with greater knowledge
of screening and contraceptive methods [16,24] and usage
of these methods [45-47]. Also not examined in this
study, other studies have reported greater knowledge
about cancer screening and contraception among women
with more years of formal education [14,15,21,22,25-27].
It is possible that private medical insurance might be a
rough proxy for having or visiting an obstetrician/gyne-
cologist or primary care provider and receiving informa-
tion about cancer screening or contraceptive methods.
However, we cannot determine from the results of this
study if women with private medical insurance are receiv-
ing more comprehensive health care education from their
medical providers or from other sources. It is probably
true that health care education from whatever source and
usage synergistically contributes to greater knowledge and
utilization. Women who were using or had recently used
screening and contraceptive methods generally answered
more questions correctly than other women. However, we
cannot determine causal or temporal relationships from
this survey. Women with a greater knowledge of preven-
tive health may undergo screening more frequently, or
women undergoing screening may learn more about the
purpose and recommended intervals of screening through
the screening process. Nevertheless, the association of
having private medical insurance and more recent or ever
usage of screening and contraceptive methods observed
here suggests that women without private medical insur-
ance or who have not recently undergone screening may
benefit from expanded discussions with their ED provid-
ers when assessing their need for these cancer screening
and contraceptive methods.
To our surprise, age and race/ethnicity were less consist-
ently associated with women's preventive health cancer
screening and contraceptive knowledge than anticipated.
We expected that age would be a strongly associated factor
with knowledge since age reflects information gathered
over repeated exposure to screening, life experiences, and
educational opportunities. Age has been associated with
women's cancer screening and contraceptive knowledge
in other studies [9,11,22,26,27]. There was a trend of
lesser knowledge among the Hispanic/Latina participants
in the survey. Other studies have observed reduced cancer
screening or contraception knowledge among Hispanics/
Latinas [22,23,27,29]. However, we anticipated that race/
ethnicity, which is associated with access to medical care,
socioeconomic status, and educational levels, to be
strongly associated with preventive health care knowledge
as it was in other studies [29,30,48]. For example, ethnic
background was associated with knowledge and under-
standing of breast-self exams, clinical breast exams and
mammograms in a 2004 study of ethno-cultural groups in
Ontario [30]. Byrd et al. noted similar findings in a study
of cervical cancer screening among Hispanic women [48].BMC Women's Health 2007, 7:7 http://www.biomedcentral.com/1472-6874/7/7
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In a study by Takakuwa et al. white and Native American
respondents exhibited greater knowledge concerning the
frequency of breast self-exams than among African Amer-
ican, Asians, or Hispanics [29]. It is possible that having
private medical insurance, which is a strong marker of
access to health care, may better account for knowledge of
women's cancer screening and contraception than race/
ethnicity or age.
There are several limitations of this investigation. The
study was from a single ED and involved English-speaking
women predominately from certain demographic groups
(e.g. white, Catholic, single, privately insured), so the
study findings may not be applicable to other settings and
populations. Given our sampling techniques, we believe
that we have a representative sample of those eligible to
participate in the study. This fact combined with our rela-
tively large sample suggests that our observations, in gen-
eral, are valid. We are hopeful that our survey will be
adapted for other settings, cultures, and languages to cor-
roborate our results. It is also possible that, despite our
pilot study involving cognitive assessments and screening
of questions, the participants did not understand certain
questions, did not accurately recall their health history, or
were afraid to answer some questions. Inaccurate recall or
misunderstanding of their health history, such as incor-
rectly stating the time since the last Pap smear, might lead
to incorrect estimates of the relationship between usage
and knowledge. As we conjecture in this study, accurate
estimates of usage are likely affected by patient knowl-
edge. Since we did not review the patients' medical
records, we cannot assess the extent of this problem. It is
reassuring that few patients did not participate because of
the nature of the questions. We were unable to assess age-
specific relationships in this study, e.g., age greater than
40 and knowledge of mammograms, because we asked
patients to select their age group instead of state their age
to enhance truthfulness in responses to this question.
Conclusion
Although ED clinicians frequently ask female patients
about their usage of screening and contraceptive methods,
it is clear that patient knowledge within and across these
topics is variable and is sometimes incomplete. Women
who do not have private medical insurance and those who
have not recently or currently used a women's cancer
screening or contraceptive method have lesser knowledge
about them. ED clinicians should take into account the
potential for knowledge deficits about women's cancer
screening and contraceptive knowledge when obtaining
health histories. Future assessments that examine the
need for women's cancer screening and contraceptive
methods among ED patients and proposed interventions
to increase usage should take account the variability of
patient knowledge on these topics.
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